Immune
|
OPPORTUNITY NUMBER |
OPPORTUNITY TITLE |
AGENCY NAME |
POSTED DATE |
CLOSE DATE |
|---|---|---|---|---|
|
Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed) |
HHS-NIH11 |
08/23/2023 |
02/07/2024 |
|
|
Immune Mechanisms at the Maternal-Fetal Interface (R01 Clinical Trial Not Allowed) |
HHS-NIH11 |
06/09/2023 |
10/11/2023 |
|
|
HEAL Initiative: Toward Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required) |
HHS-NIH11 |
06/08/2023 |
10/18/2023 |
|
|
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) |
HHS-NIH11 |
11/23/2022 |
01/07/2026 |
|
|
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) |
HHS-NIH11 |
09/13/2022 |
09/07/2025 |
|
|
Identifying Host Cell Death Pathway Targets for Host-Directed Therapies for Treatment of Mtb and Mtb/HIV Co-Infection (R01 Clinical Trial Not Allowed) |
HHS-NIH11 |
08/09/2022 |
12/07/2024 |
|
|
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) |
HHS-NIH11 |
02/18/2022 |
05/07/2025 |
|
|
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed) |
HHS-NIH11 |
02/18/2022 |
05/07/2025 |
|
|
HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) |
HHS-NIH11 |
01/07/2022 |
12/06/2024 |
|
|
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed) |
HHS-NIH11 |
11/03/2021 |
01/07/2025 |
|
|
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed) |
HHS-NIH11 |
11/03/2021 |
01/07/2025 |
|
|
Pediatric Immune System Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed) |
HHS-NIH11 |
07/09/2021 |
05/07/2024 |
|
|
Development of the Fetal Immune System (R01 Clinical Trial Not Allowed) |
HHS-NIH11 |
09/09/2020 |
12/07/2023 |